UC BON.CAP.CERT. 12/24 MRK/ DE000HD0CM22 /
2024-05-28 9:45:01 AM | Chg.+4.360 | Bid11:30:16 AM | Ask11:30:16 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
185.700EUR | +2.40% | 181.770 Bid Size: 1,000 |
181.820 Ask Size: 1,000 |
MERCK KGAA O.N. | - - | 2024-12-31 | Call |
GlobeNewswire
9:00 AM
TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA